Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lipocine Inc LPCN

Healthcare
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for Central Nervous System (CNS) disorders. Its clinical development candidates include: LPCN 1154, oral brexanolone, for treatment of postpartum depression, LPCN 2101 for epilepsy, LPCN 2203 for essential tremor... see more

Recent & Breaking News (NDAQ:LPCN)

Analyst Insights behind Price Movement - Research on Lipocine, Syneron Medical, Republic Airways and Accretive Health

Accesswire November 24, 2015

Origins of Technical Movement, Pricing Tomorrow - Research on Lipocine, Syneron Medical, Republic Airways Holdings, and Accretive Health

Accesswire November 16, 2015

Lipocine Adopts Stockholder Rights Plan

GlobeNewswire November 13, 2015

Lipocine Announces Financial and Operational Results for the Third Quarter of 2015

GlobeNewswire November 12, 2015

Lipocine Announces PDUFA Goal Date for LPCN 1021 NDA

GlobeNewswire November 12, 2015

Lipocine Announces Presentation of LPCN 1021 Clinical Data at 21st Annual SMSNA Meeting

GlobeNewswire November 11, 2015

FDA Accepts for Filing Lipocine's New Drug Application for Its Oral Testosterone Replacement Product Candidate, LPCN 1021

GlobeNewswire October 29, 2015

Lipocine Announces First Subject Dosed in Multi-Dose PK Study for Its Oral Product Candidate for the Prevention of Pre-Term Birth

GlobeNewswire September 28, 2015

Lipocine to Present at Ladenburg Thalmann 2015 Healthcare Conference

GlobeNewswire September 22, 2015

Lipocine Submits New Drug Application to FDA for Its Oral Testosterone Replacement Product Candidate, LPCN 1021

GlobeNewswire August 31, 2015

Day 6 of the Shanghai Saga-Time To Make a Shopping List of Cheap Stocks to Buy (4 Stocks)

Accesswire August 27, 2015

Lipocine Announces Financial and Operational Results for the Second Quarter of 2015

GlobeNewswire August 11, 2015

Lipocine to Present at 35th Annual Canaccord Genuity Growth Conference

GlobeNewswire August 5, 2015

Lipocine's Oral Testosterone Well Tolerated in Phase 3 Study

GlobeNewswire June 29, 2015

Lipocine to Present at the JMP Securities Life Sciences Conference

GlobeNewswire June 16, 2015

Lipocine Announces Successful Completion of Food Effect Study for LPCN 1021, an Oral Testosterone Product Candidate

GlobeNewswire June 15, 2015

Lipocine Announces Development Plans for LPCN 1107

GlobeNewswire June 8, 2015

Lipocine Receives FDA Orphan Drug Designation for LPCN 1107, an Oral Product Candidate for the Prevention of Preterm Birth

GlobeNewswire June 2, 2015

Lipocine Appoints Dr. Jyrki Mattila as Chief Business Officer

GlobeNewswire May 18, 2015

Lipocine Announces Presentation of Additional LPCN 1021 Clinical Data at American Urological Association Annual Meeting

GlobeNewswire May 11, 2015